ZYDUS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS, and when can generic versions of ZYDUS drugs launch?
ZYDUS has three hundred and sixty-four approved drugs.
There is one US patent protecting ZYDUS drugs. There are twenty-five tentative approvals on ZYDUS drugs.
There are four patent family members on ZYDUS drugs in four countries and nine hundred and seven supplementary protection certificates in eighteen countries.
Summary for ZYDUS
International Patents: | 4 |
US Patents: | 1 |
Tradenames: | 295 |
Ingredients: | 286 |
NDAs: | 364 |
Patent Litigation for ZYDUS: | See patent lawsuits for ZYDUS |
Drugs and US Patents for ZYDUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms | DOXYCYCLINE | doxycycline hyclate | INJECTABLE;INJECTION | 207757-002 | Sep 28, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Zydus Pharms | GLYBURIDE | glyburide | TABLET;ORAL | 206749-003 | May 10, 2016 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Zydus Pharms | FENTANYL-25 | fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 209655-002 | Jan 24, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Zydus Pharms | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 203546-001 | Aug 6, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
International Patents for ZYDUS Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2015128877 | ⤷ Try a Trial |
India | 651MU2014 | ⤷ Try a Trial |
Philippines | 12016501686 | ⤷ Try a Trial |
South Africa | 201606075 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ZYDUS Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0770388 | 09C0018 | France | ⤷ Try a Trial | PRODUCT NAME: ESTRADIOL VALERATE; DIENOGEST; NAT. REGISTRATION NO/DATE: NL35170 20081210; FIRST REGISTRATION: BE327792 20081103 |
2487163 | 1790002-8 | Sweden | ⤷ Try a Trial | PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ATAZANAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR ATAZANAVIR SULFATE; FIRST MARKETING AUTHORIZATION NUMBER SE: EG EU/1/15/1025, 2015-07-15 |
0236684 | C300140 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: GALANTAMINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER GALANTAMINE HYDROBROMIDE; NAT. REGISTRATION NO/DATE: RVG 29073 - RVG 29076 20030702; FIRST REGISTRATION: SE 15561 - 15565 20000225 |
1429780 | 13C0012 | France | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.